Atea Pharmaceuticals Stock Options

AVIR Stock  USD 3.50  0.08  2.34%   

Atea Pharmaceuticals Market Cap Over Time

   Market Cap   
       Timeline  

Atea Total Stockholder Equity

Total Stockholder Equity

434.12 Million

At this time, Atea Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year.

Atea Pharmaceuticals Corporate Management

CPA CPAExec OfficerProfile
XiaoJian ZhouExecutive DevelopmentProfile
Jayanthi WolfExecutive AffairsProfile
Wayne CPAExecutive OfficerProfile
Ariyapadi KrishnarajVice MarketingProfile
JeanPierre SommadossiChairman, FounderProfile
John VavrickaChief OfficerProfile

Additional Tools for Atea Stock Analysis

When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.